Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
182.34
172.34
162.67
124.92
157.55
115.54
148.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
182.34
172.34
162.67
124.92
157.55
115.54
148.80
Raw Material Cost
71.14
70.26
70.48
57.63
63.38
51.63
52.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-7.28
-10.07
-9.54
-15.31
-3.61
-13.68
-2.48
Employee Cost
10.52
15.04
14.10
12.24
10.94
9.68
9.20
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
45.37
37.14
32.17
26.48
28.06
28.62
26.45
Total Expenditure (Excl Depreciation)
119.75
112.37
107.21
81.04
98.77
76.24
85.33
Operating Profit (PBDIT) excl Other Income
62.59
59.97
55.46
43.88
58.78
39.30
63.47
Other Income
6.42
6.84
10.17
5.16
3.76
2.44
1.87
Operating Profit (PBDIT)
69.01
66.81
65.63
49.04
62.54
41.74
65.34
Interest
2.44
1.17
2.28
1.71
1.85
1.41
1.05
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
66.57
65.64
63.35
47.33
60.69
40.33
64.29
Depreciation
3.88
3.86
3.81
3.25
2.83
2.67
2.58
Profit Before Tax
62.69
61.78
59.53
44.07
57.85
37.66
61.72
Tax
14.15
14.08
12.76
12.80
13.67
8.94
12.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
48.54
47.70
46.78
31.27
44.19
28.71
48.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
48.54
47.70
46.78
31.27
44.19
28.71
48.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.34
0.24
1.03
0.46
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
48.88
47.46
45.75
30.81
44.19
28.71
48.75
Equity Capital
11.29
11.29
9.72
9.72
9.72
9.72
3.80
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.33
4.2
4.71
3.17
4.55
0.3
0.58
Diluted Earnings per share
4.38
4.29
4.2
2.84
4.07
0.27
0.2
Operating Profit Margin (Excl OI)
34.33%
34.8%
34.09%
35.13%
37.31%
34.01%
42.65%
Gross Profit Margin
36.51%
38.09%
38.94%
37.89%
38.52%
34.91%
43.21%
PAT Margin
26.62%
27.68%
28.76%
25.03%
28.05%
24.85%
32.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -11.20% vs 2.73% in Dec 2025
Standalone Net Profit
QoQ Growth in quarter ended Mar 2026 is -4.09% vs -9.65% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -2.43% vs -4.08% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 212.70% vs -68.97% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Sudeep Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
182.34
436.99
-254.65
-58.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
182.34
436.99
-254.65
-58.27%
Raw Material Cost
71.14
127.57
-56.43
-44.23%
Purchase of Finished goods
0.00
6.98
-6.98
-100.00%
(Increase) / Decrease In Stocks
-7.28
7.44
-14.72
-197.85%
Employee Cost
10.52
86.56
-76.04
-87.85%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
45.37
88.73
-43.36
-48.87%
Total Expenditure (Excl Depreciation)
119.75
317.28
-197.53
-62.26%
Operating Profit (PBDIT) excl Other Income
62.59
119.71
-57.12
-47.72%
Other Income
6.42
1.67
4.75
284.43%
Operating Profit (PBDIT)
69.01
121.38
-52.37
-43.15%
Interest
2.44
13.66
-11.22
-82.14%
Exceptional Items
0.00
25.02
-25.02
-100.00%
Gross Profit (PBDT)
66.57
132.74
-66.17
-49.85%
Depreciation
3.88
30.62
-26.74
-87.33%
Profit Before Tax
62.69
120.44
-57.75
-47.95%
Tax
14.15
12.65
1.50
11.86%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
48.54
89.47
-40.93
-45.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
48.54
89.47
-40.93
-45.75%
Share in Profit of Associates
0.00
18.32
-18.32
-100.00%
Minority Interest
-0.34
0.00
-0.34
Other related items
0.00
0.00
0.00
Consolidated Net Profit
48.88
107.79
-58.91
-54.65%
Equity Capital
11.29
19.56
-8.27
-42.28%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.33
5.51
-1.18
-21.42%
Diluted Earnings per share
4.38
5.51
-1.13
-20.51%
Operating Profit Margin (Excl OI)
34.33%
27.39%
0.00
6.94%
Gross Profit Margin
36.51%
30.38%
0.00
6.13%
PAT Margin
26.62%
24.67%
0.00
1.95%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 80.17 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -11.20% vs 2.73% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -23.54%
Quarterly - Standalone Net Profit
Standalone Net Profit 25.77 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -4.09% vs -9.65% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -22.24%
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.89 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -2.43% vs -4.08% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -36.46%
Quarterly - Interest
Interest 1.97 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 212.70% vs -68.97% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 24.68%
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 36.04%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
